VanHimbergen Robert M 4

What Happened Robert M. VanHimbergen, EVP and Chief Financial Officer of Elanco Animal Health Inc., received a grant of 8.753 deferred stock units on May 1, 2026. The reported per-unit price was $22.51, giving a total reported value of approximately $197 (derivative award). This was an award/grant (code A) of deferred stock units—not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-01; Filing date: 2026-05-05 (Accession 0001724169-26-000021).
• Reported amount: 8.753 deferred stock units at $22.51 each; aggregate ~$197.
• Security type: derivative — deferred stock units (not immediate shares).
• Footnotes:
  • F1: Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent.
  • F2: Deferred stock units settle in cash or shares after termination of employment or during a specified future year per the Executive Deferral and Stock Match Plan.
• Shares owned after the transaction: not specified in the provided filing details.
• Timeliness: filing shows the report date and the transaction date; no late-filing flag is indicated in the provided data.

Context This is a typical executive compensation award (deferred stock units) that will convert to cash or shares later per the company’s deferral plan. Such awards are routine compensation and do not reflect an immediate buy or sell of shares on the open market.